TTS GROUP LIMITED
Location
Founded
1985-01-01
Website
Risk Signals
82 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Furniture, Schools and Educational Services, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about TTS GROUP LIMITED
Live alerts from global media, monitored by Business Radar
2024-08-28 (autocar.co.uk)
Audi TTS Review 2024, Price & Specs
In S form the third-generation Audi TT possesses real dynamic capability – and plenty of appeal as a classy premium coupé
Read more
2024-04-30 (thip.media)
Are Indians vaccinated with Covishield susceptible to developing TTS?
A widely shared article on Platform X claims that those who have had the Covishield vaccinations are more likely to acquire TTS.
Read more
(theglobeandmail.com)
Is This Dividend Stock a Buy Now?
Real-time index price for TSX Consumer Staples Capped Index (TTCS), along with buy or sell indicators, analysis, charts, historical performance, news and more
Read more
(wionews.com)
AstraZeneca admits in court that its Covid vaccine can ‘in very rare cases, cause TTS’
For the first time since its COVID-19 vaccine was rolled out, AstraZeneca has admitted that it can cause a rare side effect. In legal documents submitted to the United Kingdom High Court, the pharmaceutical giant accepted that its COVID-19 vaccine "can, in very rare cases, cause TTS".
Read more
(wionews.com)
AstraZeneca admits in court that its Covid vaccine can ‘in very rare cases, cause TTS’
For the first time since its COVID-19 vaccine was rolled out, AstraZeneca has admitted that it can cause a rare side effect. In legal documents submitted to the United Kingdom High Court, the pharmaceutical giant accepted that its COVID-19 vaccine "can, in very rare cases, cause TTS".
Read more
(wionews.com)
AstraZeneca admits in court that its Covid vaccine can ‘in very rare cases, cause TTS’
For the first time since its COVID-19 vaccine was rolled out, AstraZeneca has admitted that it can cause a rare side effect. In legal documents submitted to the United Kingdom High Court, the pharmaceutical giant accepted that its COVID-19 vaccine "can, in very rare cases, cause TTS".
Read more